Get started
Author

Celine Dreger

ORCID: 0009-0003-8696-7510
Observed ORCID: 0009-0003-8696-7510
OpenAlex ID: A5094219932
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al. · Clinical Cancer Research · 54
PDF
Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma
2026 · Tim Schlierkamp-Voosen, Markus Barden, et al. · Frontiers in Immunology · 1
PDF
Supplementary Figure S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al. · 1
Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Supplementary Figure S4 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Supplementary Figure S2 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Supplementary Table S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Supplementary Table S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Data from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Data from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Supplementary Figure S4 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al.
Abstract 6328: Preclinical development of CAR T cells with antigen-inducible IL-18 enforcement to treat GD2-positive solid cancers
2024 · Lena Fischer-Riepe, Sareetha Kailayangiri, et al. · Cancer Research
Works count: 14
Citation count: 56
H-index: 1
I10-index: 1
Year
Topic
Type